Skip to main content

Want a detailed portfolio tracker?

Artiva Biotherapeutics (ARTV) P/E (2024 - 2026)

Artiva Biotherapeutics (ARTV) P/E from Sep 30, 2024 to Jul 21, 2026. The TTM Artiva Biotherapeutics (ARTV) P/E is -2.91. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Artiva Biotherapeutics (ARTV)

YearP/EChange
2026-2.91+133.10%
2025-1.25-88.55%
2024-10.90N/A

Comparison Artiva Biotherapeutics (ARTV) P/E with competitors

Artiva Biotherapeutics (ARTV) P/E is -2.91.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.06%
NBYStablecoin Development Corp0.00-100.15%
ENLVEnlivex Ltd0.07-102.57%
FGENFibroGen Inc0.24-108.25%
CHRSCoherus Biosciences Inc0.85-129.15%
FBIOFortress Biotech Inc0.95-132.60%
ORMPOramed Pharmaceuticals Inc1.50-151.63%
AGENAgenus Inc3.01-203.38%
INVAInnoviva Inc3.15-208.34%
VXRTVaxart Inc3.55-221.93%
CRMDCorMedix Inc3.63-224.64%
CVACCureVac N.V.4.45-252.71%
GLPGGalapagos NV4.86-266.90%
SRPTSarepta Therapeutics Inc4.88-267.70%
ABEOAbeona Therapeutics Inc5.39-285.06%
ABUSArbutus Biopharma Corp5.60-292.21%
ZVRAZevra Therapeutics Inc5.89-302.23%
SPROSpero Therapeutics Inc6.23-313.95%
CGENCompugen Ltd6.31-316.88%
RIGLRigel Pharmaceuticals6.87-336.06%
SLXNSilexion Therapeutics Corp7.30-350.62%
OMEROmeros Corporation9.26-418.04%
AUPHAurinia Pharmaceuticals Inc9.58-429.25%
PLXProtalix BioTherapeutics Inc10.89-474.11%
ACADAcadia Pharmaceuticals Inc11.73-502.88%
TBPHTheravance Biopharma Inc12.26-521.21%
ADMAAdma Biologics Inc12.42-526.57%
HRMYHarmony Biosciences Holdings Inc13.82-574.73%
SABSSAB Biotherapeutics Inc14.14-585.58%
NAGENiagen Bioscience Inc14.82-609.01%
INCYIncyte Corp15.82-643.51%
REGNRegeneron Pharmaceuticals Inc15.86-644.68%
PBYIPuma Biotechnology Inc17.32-694.80%
CPRXCatalyst Pharmaceuticals Inc17.44-699.04%
EXELExelixis Inc17.54-702.44%
TGTXTG Therapeutics Inc18.97-751.49%
MDXGMimedx Group Inc20.55-805.98%
XOMAXOMA Royalty Corp22.87-885.77%
ARGXArgen X SE24.30-934.66%
CTMXCytomX Therapeutics Inc24.82-952.63%
XOMAOXOMA Royalty Corp25.34-970.62%
HALOHalozyme Therapeutics Inc25.62-980.20%
XOMAPXOMA Royalty Corp25.67-981.80%
VRTXVertex Pharmaceuticals Inc27.99-1061.65%
RPRXRoyalty Pharma plc - Class A28.69-1085.45%
SLNOSoleno Therapeutics Inc29.02-1096.71%
ASNDAscendis Pharma A/S30.09-1133.47%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1402.32%
APLSApellis Pharmaceuticals Inc39.02-1440.42%
BMRNBiomarin Pharmaceutical Inc42.21-1550.03%
KRYSKrystal Biotech Inc45.34-1657.60%
ONCBeiGene Ltd69.54-2488.80%
PHARPharming Group N.V.75.03-2677.22%
TECHBio-Techne Corp101.96-3602.39%
VCELVericel Corp109.92-3875.93%
ALNYAlnylam Pharmaceuticals Inc117.96-4152.24%
GMABGenmab140.29-4919.16%
TLXTelix Pharmaceuticals Ltd162.15-5670.14%
CORTCorcept Therapeutics Inc212.86-7411.91%